The Department of Health and Human Services has proposed a rule to end the rebate system between PBMs and drugmakers. The Trump administration has been critical of the “middlemen” and the complex rebate system. The proposal would allow rebates to be offered directly to patients and enable PBMs to establish fixed fee service arrangements with drugmakers that could replace lost revenue from rebates. (Reuters)

UnitedHealth Group has gone to court to stop former executive Atul Gawande from working for the Amazon, Berkshire Hathaway, and JP Morgan health venture. The lawsuit is trying to stop Gawande, who was brought on to lead the initiative in June, from working for a UnitedHealth competitor. (Wall Street Journal)

Teva’s generic EpiPen launch has stalled five months after approval, with many pharmacies and distributors not having its version of EpiPen yet. Mylan’s EpiPen has been experiencing shortages, leaving consumers looking for an alternative. (Reuters)

General Electric is expecting to sell half of its health unit, more than previously planned. The company wants to both sell about half of the health unit and spin off the remainder into a separate company. The deal could fetch as much as $50 billion, according to CEO Larry Culp. (CNBC)

MJH Associates has acquired media assets from the UBM Life Sciences Group. MJH added multimedia platforms in healthcare, animal care, pharma sciences, and dental fields, as well as three veterinarian conferences. The health education, research, and comms firm also created a new business unit to house the acquisitions, MultiMedia Healthcare. (Press release)